These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31079817)

  • 1. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
    Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
    Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
    Gogas BD; Serruys PW; Diletti R; Farooq V; Brugaletta S; Radu MD; Heo JH; Onuma Y; van Geuns RJ; Regar E; De Bruyne B; Chevalier B; Thuesen L; Smits PC; Dudek D; Koolen J; Windecker S; Whitbourn R; Miquel-Hebert K; Dorange C; Rapoza R; Garcia-Garcia HM; McClean D; Ormiston JA
    JACC Cardiovasc Interv; 2012 Jun; 5(6):656-65. PubMed ID: 22721662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study.
    Zhang YJ; Iqbal J; Nakatani S; Bourantas CV; Campos CM; Ishibashi Y; Cho YK; Veldhof S; Wang J; Onuma Y; Garcia-Garcia HM; Dudek D; van Geuns RJ; Serruys PW;
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1361-9. PubMed ID: 25457053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial.
    Garcia-Garcia HM; Haude M; Kuku K; Hideo-Kajita A; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Dijkstra J; Waksman R
    Int J Cardiol; 2018 Mar; 255():22-28. PubMed ID: 29292064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries.
    Zeng Y; Tateishi H; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Nie S; Jonker H; Dijkstra J; Radu MD; Räber L; McClean DR; van Geuns RJ; Christiansen EH; Fahrni T; Koolen J; Onuma Y; Bruining N; Serruys PW
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1151-1161. PubMed ID: 28330651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study.
    Seguchi M; Aytekin A; Xhepa E; Haude M; Wlodarczak A; van der Schaaf RJ; Torzewski J; Ferdinande B; Escaned J; Iglesias JF; Bennett J; Toth GG; Toelg R; Wiemer M; Olivecrona G; Vermeersch P; Waksman R; Garcia-Garcia HM; Joner M
    EuroIntervention; 2024 Sep; 20(18):e1173-e1183. PubMed ID: 39279514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality imaging of attenuated plaque using grayscale and virtual histology intravascular ultrasound and optical coherent tomography.
    Kang SJ; Ahn JM; Han S; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E1-E11. PubMed ID: 25511369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents.
    Ribamar Costa J; Abizaid A; Sousa A; Siqueira D; Chamié D; Feres F; Costa R; Staico R; Maldonado G; Centemero M; Tanajura LF; Viana R; Chaves Á; Abizaid A; Sousa JE
    EuroIntervention; 2012 Jun; 8(2):225-34. PubMed ID: 22717925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
    Brugaletta S; Garcia-Garcia HM; Garg S; Gomez-Lara J; Diletti R; Onuma Y; van Geuns RJ; McClean D; Dudek D; Thuesen L; Chevalier B; Windecker S; Whitbourn R; Dorange C; Miquel-Hebert K; Sudhir K; Ormiston JA; Serruys PW
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):859-66. PubMed ID: 20941544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities.
    Brugaletta S; Costa JR; Garcia-Garcia HM
    Int J Cardiovasc Imaging; 2011 Feb; 27(2):239-48. PubMed ID: 21279692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT.
    Diletti R; Garcia-Garcia HM; Gomez-Lara J; Brugaletta S; Wykrzykowska JJ; van Ditzhuijzen N; van Geuns RJ; Regar E; Ambrosio G; Serruys PW
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):774-80. PubMed ID: 21757169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
    Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Endothelial Shear Stress on Absorption Process of Resorbable Magnesium Scaffold: A BIOSOLVE-II Substudy.
    Ozaki Y; Kuku KO; Sakellarios A; Haude M; Hideo-Kajita A; Desale S; Siogkas P; Sioros S; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Michalis L; Fotiadis DI; Djikstra J; Waksman R; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2021 Aug; 29():9-15. PubMed ID: 33863661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.
    Gómez-Lara J; Brugaletta S; Diletti R; Gogas BD; Farooq V; Onuma Y; Gobbens P; Van Es GA; García-García HM; Serruys PW
    Catheter Cardiovasc Interv; 2012 May; 79(6):890-902. PubMed ID: 21523891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study.
    Atary JZ; Bergheanu SC; van der Hoeven BL; Atsma DE; Bootsma M; van der Kley F; Zeppenfeld K; Jukema JW; Schalij MJ
    EuroIntervention; 2009 Nov; 5(5):565-72. PubMed ID: 20142177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial): Results From the OPINION Imaging Study.
    Otake H; Kubo T; Takahashi H; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Kozuma K; Ioji T; Kaneda H; Akasaka T;
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):111-123. PubMed ID: 28917678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study.
    Shin ES; Garcia-Garcia HM; Garg S; Ligthart J; Thuesen L; Dudek D; Ormiston JA; Serruys PW
    Int J Cardiovasc Imaging; 2011 Oct; 27(7):931-7. PubMed ID: 21080074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.